Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Clinical comparison of /sup 99m/Tc N,N'-bis(mercaptoacetamido)ethylenediamine and (/sup 131/I)ortho-iodohippurate for evaluation of renal tubular function: concise communication

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6816787
Recent experiments in normal animals have shown that /sup 99m/Tc N,N'-bis(mercaptoacetamido)ethylenediamine (/sup 99m/Tc DADS) is a potential technetium-99m-labeled replacement for (/sup 131/I)ortho-iodohippurate. We compared the two agents in eleven patients with renal transplants (serum creatinine range: 0.9--5.7 mg/dl). Digital and analog images were recorded for 30 min and after voiding. The results indicate that the relative extraction efficiency index of /sup 99m/Tc DADS is 76% +/- 3 (mean +/- s.e.m.), that the leading-edge parenchymal transit time of /sup 99m/Tc DADS is 137% +/- 6, and that the percentage of injected /sup 99m/Tc DADS in the bladder at 30 min is 25% +/- 4 of that of /sup 131/I Hipp (all p less than 0.05). Forty percent of patients showed some hepatobiliary excretion of /sup 99m/Tc DADS. We conclude that the biologic properties of /sup 99m/Tc DADS are inferior to those of /sup 131/I Hipp and that analogs of /sup 99m/Tc DADS should be evaluated in an attempt to find a more suitable technetium-99m-labeled replacement for /sup 131/I Hipp.
Research Organization:
University of Colorado Health Sciences Center, Denver
OSTI ID:
6816787
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 23:5; ISSN JNMEA
Country of Publication:
United States
Language:
English